MaxCyte (MXCT) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MaxCyte, Inc. has announced a change in major holdings as BlackRock, Inc. now holds 8.52% of the company’s voting rights, following a recent acquisition. This development is significant for investors tracking major moves in the biotech sector, as it may influence MaxCyte’s strategic decisions and market performance.
For further insights into MXCT stock, check out TipRanks’ Stock Analysis page.